Cytotoxic and genotoxic effects of abamectin, chlorfenapyr, and imidacloprid on CHOK1 cells

Al-Sarar, Ali S.; Abobakr, Yasser; Bayoumi, Alaa Eldin; Hussein, Hamdy I.;

Abstract


The cytotoxicity and genotoxicity of abamectin, chlorfenapyr, and imidacloprid have been evaluated on the Chinese hamster ovary (CHOK1) cells. Neutral red incorporation (NRI), total cellular protein content (TCP), and methyl tetrazolium (MTT) assays were followed to estimate the mid-point cytotoxicity values, NRI50, TCP50, and MTT50, respectively. The effects of the sublethal concentration (NRI25) on glutathione S-transferase (GST), glutathione reductase (GRD), glutathione peroxidase (GPX), and total glutathione content have been evaluated in the presence and absence of reduced glutathione (GSH), vitamin C, and vitamin E. The genotoxicity was evaluated using chromosomal aberrations (CA), micronucleus (MN) formation, and DNA fragmentation techniques in the presence and absence of the metabolic activation system, S9 mix. Abamectin was the most cytotoxic pesticide followed by chlorfenapyr, while imidacloprid was the least cytotoxic one. The glutathione redox cycle components were altered by the tested pesticides in the absence and presence of the tested antioxidants. The results of genotoxicity indicate that abamectin, chlorfenapyr, and imidacloprid have potential genotoxic effects on CHOK1 cells under the experimental conditions.


Other data

Title Cytotoxic and genotoxic effects of abamectin, chlorfenapyr, and imidacloprid on CHOK1 cells
Authors Al-Sarar, Ali S.; Abobakr, Yasser; Bayoumi, Alaa Eldin ; Hussein, Hamdy I.
Keywords Abamectin | Chlorfenapyr | CHOK1 cells | Cytotoxicity | Genotoxicity | Glutathione redox cycle | Imidacloprid
Issue Date 1-Jul-2015
Journal Environmental Science and Pollution Research 
ISSN 09441344
DOI 10.1007/s11356-015-4927-3
PubMed ID 26122579
Scopus ID 2-s2.0-84945468938

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.